Cargando…

Alterations in HLA Class I-Presented Immunopeptidome and Class I-Interactome upon Osimertinib Resistance in EGFR Mutant Lung Adenocarcinoma

SIMPLE SUMMARY: We sought to identify molecular mechanisms of lower efficacy of immunotherapy in epidermal growth factor receptor (EGFR) mutant lung adenocarcinoma and the differences in those mechanisms with the emergence of tyrosine kinase inhibitor (TKI)-resistance. To this end, we conducted affi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Yue A., Maity, Tapan K., Gao, Shaojian, Gong, Tao, Bahta, Meriam, Venugopalan, Abhilash, Zhang, Xu, Guha, Udayan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507780/ https://www.ncbi.nlm.nih.gov/pubmed/34638461 http://dx.doi.org/10.3390/cancers13194977

Ejemplares similares

Proteogenomic Analysis Unveils the HLA Class I-Presented Immunopeptidome in Melanoma and EGFR-Mutant Lung Adenocarcinoma
por: Qi, Yue A., et al.
Publicado: (2021)

The HLA class I immunopeptidomes of AAV capsid proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2023)

Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance
por: Melief, Cornelis J. M., et al.
Publicado: (2017)

The HLA class-II immunopeptidomes of AAV capsids proteins
por: Brito-Sierra, Carlos A., et al.
Publicado: (2022)

MHC Class I Immunopeptidome: Past, Present, and Future
por: Yewdell, Jonathan W.
Publicado: (2022)

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins
Publicado: (2023)

Identification of neoepitope reactive T-cell receptors guided by HLA-A*03:01 and HLA-A*11:01 immunopeptidomics
por: Ade, Catherine M, et al.
Publicado: (2023)

Database search engines and target database features impinge upon the identification of post‐translationally cis‐spliced peptides in HLA class I immunopeptidomes
por: Mishto, Michele, et al.
Publicado: (2022)

Novel CDK12/13 Inhibitors AU-15506 and AU-16770 Are Potent Anti-Cancer Agents in EGFR Mutant Lung Adenocarcinoma with and without Osimertinib Resistance
por: Maity, Tapan K., et al.
Publicado: (2023)

Variations in MHC class I antigen presentation and immunopeptidome selection pathways
por: Zaitouna, Anita J., et al.
Publicado: (2020)

Understanding the constitutive presentation of MHC class I immunopeptidomes in primary tissues
por: Kubiniok, Peter, et al.
Publicado: (2022)

Mild Acid Elution and MHC Immunoaffinity Chromatography Reveal Similar Albeit Not Identical Profiles of the HLA Class I Immunopeptidome
por: Sturm, Theo, et al.
Publicado: (2020)

A tissue-based draft map of the murine MHC class I immunopeptidome
por: Schuster, Heiko, et al.
Publicado: (2018)

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome
por: Brown, Scott D., et al.
Publicado: (2018)

Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
por: Leddy, Owen, et al.
Publicado: (2023)

Clonal Evolution and Heterogeneity of Osimertinib Acquired Resistance Mechanisms in EGFR Mutant Lung Cancer
por: Roper, Nitin, et al.
Publicado: (2020)

Protocol for purification and identification of MHC class I immunopeptidome from cancer cell lines
por: Mohan, Sonali V., et al.
Publicado: (2021)

Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment
por: Newey, Alice, et al.
Publicado: (2019)

Upregulation of HLA Class I Expression on Tumor Cells by the Anti-EGFR Antibody Nimotuzumab
por: Garrido, Greta, et al.
Publicado: (2017)

iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity
por: Suzuki, Daisuke, et al.
Publicado: (2019)

SCAMP3 is a mutant EGFR phosphorylation target and a tumor suppressor in lung adenocarcinoma
por: Venugopalan, Abhilash, et al.
Publicado: (2021)

Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
por: Boehm, Kevin Michael, et al.
Publicado: (2019)

The Immunopeptidome from a Genomic Perspective: Establishing the Noncanonical Landscape of MHC Class I–Associated Peptides
por: Bedran, Georges, et al.
Publicado: (2023)

HLA class I allele promiscuity revisited
por: Rao, Xiangyu, et al.
Publicado: (2011)

The pockets guide to HLA class I molecules
por: Nguyen, Andrea T., et al.
Publicado: (2021)

The Association of HLA-Class I and Class II with Hodgkin's Lymphoma in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2014)

HLA Class I and Class II Associations with ESRD in Saudi Arabian Population
por: Hamdi, Nuha Mahmoud, et al.
Publicado: (2014)

Association of HLA-A and Non-Classical HLA Class I Alleles
por: Carlini, Federico, et al.
Publicado: (2016)

Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome
por: Santambrogio, Laura
Publicado: (2022)

HLA-I immunopeptidome profiling of human cells infected with high-containment enveloped viruses
por: Weingarten-Gabbay, Shira, et al.
Publicado: (2022)

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics
por: Nagler, Adi, et al.
Publicado: (2021)

ROLE OF HLA CLASS-I ANTIGENS IN DELUSIONAL DISORDER
por: Debnath, Monojit, et al.
Publicado: (2000)

Distribution of HLA class I alleles and haplotypes in Korean.
por: Kim, T. G., et al.
Publicado: (1993)

HLA class I alleles frequencies in the Syrian population
por: Ikhtiar, Adnan M., et al.
Publicado: (2018)

Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule
Publicado: (1990)

Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients
por: Huang, Xin, et al.
Publicado: (2010)

Endo-lysosomal assembly variations among human leukocyte antigen class I (HLA class I) allotypes
por: Olson, Eli, et al.
Publicado: (2023)

Borrelia burgdorferi-Induced Changes in the Class II Self-Immunopeptidome Displayed on HLA-DR Molecules Expressed by Dendritic Cells
por: Gutierrez-Hoffmann, Maria G., et al.
Publicado: (2020)

Associations of Moyamoya patients with HLA class I and class II alleles in the Korean population.
por: Han, Hoon, et al.
Publicado: (2003)

HLA Class I or Class II and Disease Association: Catch the Difference If You Can
por: Fiorillo, Maria Teresa, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_7uhe6hh8rt6ia3c5vrq9j2cead